Interferon-γ1b therapy in idiopathic pulmonary fibrosis: A metaanalysis

Chest

Volumn 128, Issue 1, 2005, Pages 203-206

  Bajwa, Ednan K ^a   Ayas, Najib T ^b   Schuzer, Michael ^b   Mak, Edwin ^b   Ryu, Jay H ^c   Malhotra, Atul ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c MAYO CLINIC   (United States)

Author keywords

Interferon; Lung; Pulmonary fibrosis; Restriction; Survival; Treatment

Indexed keywords

COLCHICINE; GAMMA1B INTERFERON; PREDNISOLONE; RECOMBINANT GAMMA INTERFERON;

ARTICLE; CLINICAL TRIAL; CONFIDENCE INTERVAL; DRUG EFFICACY; FATALITY; FIBROSING ALVEOLITIS; HAZARD ASSESSMENT; HUMAN; LUNG FIBROSIS; META ANALYSIS; MORTALITY; PRIORITY JOURNAL; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SURVIVAL; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

HUMANS; INTERFERON-GAMMA, RECOMBINANT; PULMONARY FIBROSIS;

EID: 22244460509     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.128.1.203     Document Type: Article

References (21)

1. Douglas WW, Ryu JH, Schroeder DR. Idiopathic pulmonary fibrosis: impact of oxygen and colchicine, prednisone, or no therapy on survival. Am J Respir Crit Care Med 2000; 161:1172-1178
2. Gross TJ, Hunninghake GW. Idiopathic pulmonary fibrosis. N Engl J Med 2001; 345:517-525
3. Honore I, Nunes H, Groussard O, et al. Acute respiratory failure after interferon-γ therapy of end-stage pulmonary fibrosis. Am J Respir Crit Care Med 2003; 167:953-957
4. Kalra S, Utz JP, Ryu JH. Interferon γ-1b therapy for advanced idiopathic pulmonary fibrosis. Mayo Clin Proc 2003; 78:1082-1087
5. Chapman HA. Disorders of lung matrix remodeling. J Clin Invest 2004; 113:148-157
6. Okada T, Sugie I, Aisaka K. Effects of γ-interferon on collagen and histamine content in bleomycin-induced lung fibrosis in rats. Lymphokine Cytokine Res 1993; 12:87-91
7. Narayanan AS, Whithey J, Souza A, et al. Effect of γ-interferon on collagen synthesis by normal and fibrotic human lung fibroblasts. Chest 1992; 101:1326-1331
8. Lukacs NW, Hogaboam C, Chensue SW, et al. Type 1/type 2 cytokine paradigm and the progression of pulmonary fibrosis. Chest 2001; 120(suppl):5S-8S
9. Clark JG, Dedon TF, Wayner EA, et al. Effects of interferon-γ on expression of cell surface receptors for collagen and deposition of newly synthesized collagen by cultured human lung fibroblasts. J Clin Invest 1989; 83:1505-1511
10. Duits LA, Ravensbergen B, Rademaker M, et al. Expression of β-defensin 1 and 2 mRNA by human monocytes, macrophages and dendritic cells. Immunology 2002; 106:517-525
11. Nathan CF, Murray HW, Wiebe ME, et al. Identification of interferon-γ as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity. J Exp Med 1983; 158:670-689
12. Nathan CF, Prendergast TJ, Wiebe ME, et al. Activation of human macrophages: comparison of other cytokines with interferon-γ. J Exp Med 1984; 160:600-605
13. Ziesche R, Hofbauer E, Wittmann K, et al. A preliminary study of long-term treatment with interferon γ-1b and low-dose prednisolone in patients with idiopathic pulmonary fibrosis. N Engl J Med 1999; 341:1264-1269
14. Raghu G, Brown KK, Bradford WZ, et al. A placebo-controlled trial of interferon γ-1b in patients with idiopathic pulmonary fibrosis. N Engl J Med 2004; 350:125-133
15. Teirstein AS. The elusive goal of therapy for usual interstitial pneumonia. N Engl J Med 2004; 350:181-183
16. Parmar M, Torri V, Stewart L. Extracting summary statistics to perform meta-analysis of the published literature for survival endpoints. Stat Med 2004; 23:1817
17. Strieter RM, Starko KM, Enelow RI, et al. Effects of interferon γ-1b on biomarker expression in idiopathic pulmonary fibrosis patients. Am J Respir Crit Care Med 2004; 170:133-140
18. Antoniou K, Polychronopoulos V, Dimadi M, et al. Comparison of interferon γ-1b (IFN-) and colchicines in the treatment of idiopathic pulmonary fibrosis: preliminary results of a prospective, multicenter randomized study. Paper presented at: the 99th International Conference of the American Thoracic Society; May 16-21, 2003, Seattle, WA
19. Ziesche RB, Crager M, Block L. Long-term survival in idiopathic pulmonary fibrosis patients treated with interferon γ-1b. Paper presented at: CHEST 2002: the 68th annual meeting of American College of Chest Physicians; November 2-7, 2002; San Diego, CA
20. Prasse A, Muller KM, Kurz C, et al. Does interferon-γ improve pulmonary function in idiopathic pulmonary fibrosis? Eur Respir J 2003; 22:906-911
21. Douglas WW, Ryu JH, Swensen SJ, et al. Colchicine versus prednisone in the treatment of idiopathic pulmonary fibrosis: a randomized prospective study-Members of the Lung Study Group. Am J Respir Crit Care Med 1998; 158:220-225